Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by William W. Ho
Use of Angiotensin System Inhibitors Is Associated With Immune Activation and Longer Survival in Non-Metastatic Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival
Oncology Letters
Cancer Research
Oncology
Increased CDC20 Expression Is Associated With Pancreatic Ductal Adenocarcinoma Differentiation and Progression
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma
Frontiers in Oncology
Cancer Research
Oncology
Elevated McP-1 Is Associated With Cancer Cachexia in Patients With Pancreatic Ductal Adenocarcinoma
HPB
Hepatology
Gastroenterology
Infiltrating Immune Cells and Gene Mutations in Pancreatic Ductal Adenocarcinoma
British Journal of Surgery
Surgery
Nationwide Trends in Incidence, Treatment and Survival of Pancreatic Ductal Adenocarcinoma
European Journal of Cancer
Cancer Research
Oncology
CCAT2 Is an Oncogenic Long Non-Coding RNA in Pancreatic Ductal Adenocarcinoma
Biological Research
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Switchable CAR-T Cells Mediate Remission in Metastatic Pancreatic Ductal Adenocarcinoma
Gut
Gastroenterology
Use of Renin-Angiotensin System Inhibitors Is Associated With Reduction of Fracture Risk in Hemodialysis Patients
PLoS ONE
Multidisciplinary